Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—N.D. Cal.: Baby food MDL is dismissed for lack of federal jurisdiction
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Medicare reactivation effective date tied to receipt of approved revalidation application
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—FINAL RULES: DEA revokes exempted status for inactive butalbital products
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ELECTRONIC HEALTH RECORDS—W.D. Ky.: Humana privacy lawsuit advances over alleged tracking of health information
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—FDA opens applications for new pilot to shorten drug approval times: What sponsors need to know
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FOOD SAFETY—FDA GUIDANCE NOTICES: FDA issues draft guidance on requirements for food traceability records
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: FDA classifies cell enrichment kit
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PREEMPTION OF STATE LAW—1st Cir.: Seizure patient’s estate may amend complaint against Amgen about Aimovig biologic labeling
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • RURAL HEALTH CLINICS—GAO REPORTS: CMS awarded states $10 billion in RHT program funding
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS—FDA opens applications for new pilot to shorten drug approval times: What sponsors need to know, (Oct 15, 2026)

    Law Firms Mentioned:Sheppard, Mullin, Richter & Hampton LLP

    By Justine Lei and Jami Fogelhut of Sheppard, Mullin, Richter & Hampton LLP

    Earlier this month, FDA opened applications for a new Expedited Investigational New Drug (IND) Pilot Program (the "Program"), an initiative launched under HHS Operation TrialBlazer[1] that aims to shorten the path from IND-enabling activities to firs ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use